Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
AstraZeneca
Moodys
QuintilesIMS
Chubb
Chinese Patent Office
Julphar
Boehringer Ingelheim
Argus Health

Generated: December 14, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR LULICONAZOLE

« Back to Dashboard

Clinical Trials for Luliconazole

Trial ID Title Status Sponsor Phase Summary
NCT00869336 Multicenter Study of the Efficacy and Safety of Luliconazole Cream in Tinea Pedis (Athlete's Foot) Completed Tinea Pharmaceuticals Phase 2 To examine the safety and optimal duration of Luliconazole Cream 1% treatments for 14 days or 28 days to achieve "complete clearance" at 2 weeks post treatment.
NCT01044381 Open-Label Pharmacokinetics (PK)/Safety Study of Luliconazole Solution, 10% in Distal Subungual Onychomycosis Completed Topica Pharmaceuticals Phase 1/Phase 2 To determine the safety, tolerability, systemic exposure and pharmacokinetics of luliconazole after repeat daily topical application of Luliconazole Solution, 10% in a maximal use setting in adults with distal subungual onychomycosis of the toenails.
NCT01431820 Safety and Efficacy of Luliconazole Solution, 10% in Subjects With Mild to Moderate Onychomycosis Completed Topica Pharmaceuticals Phase 2/Phase 3 The purpose of this study is to determine the safety and efficacy of a topical antifungal formulation, Luliconazole Solution, 10%, in the treatment of adults with onychomycosis of the toenails.
NCT02394340 Study Evaluating the Drug Interaction Potential of Luliconazole Cream 1% in Subjects With Tinea Pedis and Tinea Cruris Recruiting Valeant Pharmaceuticals International, Inc. Phase 4 This is an open-label, maximal use study evaluating the drug interaction potential of luliconazole cream 1% in subjects with tinea pedis and tinea cruris
NCT02394340 Study Evaluating the Drug Interaction Potential of Luliconazole Cream 1% in Subjects With Tinea Pedis and Tinea Cruris Recruiting Bausch & Lomb Incorporated Phase 4 This is an open-label, maximal use study evaluating the drug interaction potential of luliconazole cream 1% in subjects with tinea pedis and tinea cruris
NCT02491112 A Randomized Study Evaluating the Safety and Efficacy of Luliconazole Cream in Pediatric Subjects With Tinea Corporis Not yet recruiting Valeant Pharmaceuticals Phase 4 The objective of this study is to evaluate the safety and efficacy of Luliconazole Cream 1% when applied topically for 7 days in pediatric subjects 2 years to 17 years of age with tinea corporis.
NCT02767271 Maximal Use of Luliconazole Cream 1% in Pediatric Patients With Moderate to Severe Tinea Pedis or Tinea Cruris Active, not recruiting Valeant Pharmaceuticals International, Inc. Phase 4 The objective of this study is to evaluate the pharmacokinetics of Luliconazole Cream 1% in subjects with moderate to severe tinea pedis or tinea cruris.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Luliconazole

Condition Name

Condition Name for Luliconazole
Intervention Trials
Tinea Pedis 3
Tinea Cruris 2
Tinea 1
Onychomycosis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Luliconazole
Intervention Trials
Tinea 4
Tinea Pedis 3
Onychomycosis 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Luliconazole

Trials by Country

Trials by Country for Luliconazole
Location Trials
United States 24
Honduras 1
Dominican Republic 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Luliconazole
Location Trials
Texas 3
Oregon 2
Minnesota 2
California 1
Colorado 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Luliconazole

Clinical Trial Phase

Clinical Trial Phase for Luliconazole
Clinical Trial Phase Trials
Phase 4 3
Phase 2/Phase 3 1
Phase 2 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Luliconazole
Clinical Trial Phase Trials
Completed 3
Not yet recruiting 1
Recruiting 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Luliconazole

Sponsor Name

Sponsor Name for Luliconazole
Sponsor Trials
Valeant Pharmaceuticals International, Inc. 2
Topica Pharmaceuticals 2
Valeant Pharmaceuticals 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Luliconazole
Sponsor Trials
Industry 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
AstraZeneca
US Army
Accenture
McKinsey
Citi
US Department of Justice
Mallinckrodt
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.